Trial intelligence / Profile preview

PDT with Levulan and Blue Light for Actinic Cheilitis

NCT02409732Phase 4Completed

Sponsor
Dartmouth Health
Start
Apr 2015
Primary completion
Jul 2017
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of aminolevulinic acid in actinic cheilitis (AC), sponsored by Dartmouth Health. Started Apr 2015; status: completed.

02

Drugs

aminolevulinic acid
03

Conditions

actinic cheilitis (AC)

Beyond the preview

Go deeper on NCT02409732.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02409732.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call